Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
1.870
-0.130 (-6.50%)
Dec 23, 2024, 4:00 PM EST - Market closed
Standard BioTools Revenue
Standard BioTools had revenue of $44.97M in the quarter ending September 30, 2024, with 77.27% growth. This brings the company's revenue in the last twelve months to $155.90M, up 48.23% year-over-year. In the year 2023, Standard BioTools had annual revenue of $106.34M with 8.57% growth.
Revenue (ttm)
$155.90M
Revenue Growth
+48.23%
P/S Ratio
3.35
Revenue / Employee
$289,243
Employees
539
Market Cap
696.12M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 106.34M | 8.39M | 8.57% |
Dec 31, 2022 | 97.95M | -32.63M | -24.99% |
Dec 31, 2021 | 130.58M | -7.56M | -5.47% |
Dec 31, 2020 | 138.14M | 20.90M | 17.83% |
Dec 31, 2019 | 117.24M | 4.28M | 3.79% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Avanos Medical | 681.50M |
Bioventus | 555.06M |
Relay Therapeutics | 10.01M |
Oculis Holding AG | 1.03M |
Keros Therapeutics | 651.00K |
LAB News
- 4 days ago - Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Standard BioTools Appoints Alex Kim as Chief Financial Officer - GlobeNewsWire
- 7 weeks ago - Standard BioTools to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - Standard BioTools Inc. (LAB) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Standard BioTools Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024 - GlobeNewsWire
- 4 months ago - Standard BioTools And 2 Other Penny Stocks Executives Are Buying - Benzinga
- 4 months ago - Standard BioTools And 3 Other Stocks Under $3 Executives Are Buying - Benzinga